Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DEAH-box helicase 15 (DHX15) is an ATP-dependent RNA helicase and pre-mRNA splicing factor encoded by the DHX15 gene. It is part of the DEAH/RHA-box family of RNA helicases, defined by tandem RecA-like domains and a conserved DEAH (Asp-Glu-Ala-His) signature[6][5][7]. DHX15 catalyzes RNA duplex unwinding by hydrolyzing ATP and remodels ribonucleoprotein complexes, functioning in spliceosome disassembly, ribosome maturation, and regulating RNA-protein interactions critical for proper gene expression[1][2]. DHX15’s enzymatic activity and substrate specificity are tightly regulated via recruitment by adapter proteins, most notably G-patch domain-containing proteins, which stabilize its conformation and boost its ATPase and helicase activities[1][4]. Beyond RNA processing, DHX15 plays a key role in innate immune signaling, acting as a cofactor for pattern-recognition receptors (such as NLRP6 and RIG-I), where it binds viral double-stranded RNA and triggers immune cascades, including inflammasome assembly and interferon production[3]. Abnormal regulation or expression of DHX15 is associated with cancer (e.g., T-cell acute lymphoblastic leukemia via effects on RNA splicing and activation of oncogenic pathways)[6], and it can serve as a host factor exploited by viruses for genomic RNA packaging and replication[4]. Due to its broad and essential cellular roles, DHX15 is considered a potential target for both cancer therapy and antiviral strategies, but its inhibition poses significant safety and selectivity challenges.
ATP-dependent unwinding and remodeling of RNA and RNA-protein complexes, facilitated by interaction with G-patch cofactors[1][2][4]. Recruitment by cofactors (e.g., G-patch proteins, pattern recognition receptors) modulates DHX15 cellular localization and activity[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAH-box helicase 15 (DHX15).